DiaMedica Therapeutics Inc. Common Stock
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell DMAC and other ETFs, options, and stocks.About DMAC
DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD).
DMAC Key Statistics
Stock Snapshot
The current DiaMedica Therapeutics Inc. Common Stock(DMAC) stock price is $7.58, with a market capitalization of 394.23M. The stock trades at a price-to-earnings (P/E) ratio of -10.56.
As of 2026-01-17, DiaMedica Therapeutics Inc. Common Stock(DMAC) stock has fluctuated between $7.49 and $8.62. The current price stands at $7.58, placing the stock +1.2% above today's low and -12.2% off the high.
The DiaMedica Therapeutics Inc. Common Stock(DMAC)'s current trading volume is 614.35K, compared to an average daily volume of 245.94K.
During the past year, DiaMedica Therapeutics Inc. Common Stock(DMAC) stock moved between $3.19 at its lowest and $10.42 at its peak.
During the past year, DiaMedica Therapeutics Inc. Common Stock(DMAC) stock moved between $3.19 at its lowest and $10.42 at its peak.